Micafungin for the treatment of invasive aspergillosis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference115 articles.
1. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients;Viscoli;J Antimicrob Chemother,2009
2. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial);Cornely;Clin Infect Dis,2007
3. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis;Herbrecht;N Engl J Med,2002
4. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study;Herbrecht;Bone Marrow Transplant,2010
5. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature;Espinel-Ingroff;Rev Iberoam Micol,2003
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-18
2. A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections;Mycoses;2023-06-10
3. Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading;Mycopathologia;2023-04-26
4. Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan;Journal of Microbiology, Immunology and Infection;2023-04
5. AfSec1 is a signal peptidase and removes signal peptides of 1,3-β-glucanosyltransferases in Aspergillus fumigatus;Medical Mycology;2022-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3